The detection of ketamine through drug testing relies on identifying the parent compound or its metabolites within a biological sample. Standard drug screening panels do not typically include specific tests for this substance, meaning specialized assays are required for its identification. If a test is designed to detect it, the presence of ketamine or its metabolites, such as norketamine, would indicate a positive result.
Accurate and timely detection of ketamine is crucial in various settings, including forensic investigations, clinical monitoring, and workplace drug screening programs where its use is prohibited. Historically, the relatively short detection window posed a challenge, but advancements in analytical techniques have improved the ability to identify ketamine use over a longer period. This has significant implications for ensuring compliance with regulations and preventing potential misuse or diversion.
